Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
The primary objective of the study is to describe the real-life conditions of use and
 exposure of cabozantinib in France in two cohorts defined by their treatment initiation
 period.
Inclusion Criteria:

 -  Any subjects from the participating sites (dead or alive) who have received at least
 one dose of cabozantinib within the ATU program or between 10/12/2016 and 16/02/2018
 and for whom the medical file is available

 Exclusion Criteria:

 -  Patients alive at study initiation who have not received information notice

 -  who have opposed to data collection.